HK1202335A1 - 細胞和其它複雜生物材料的色譜分離 - Google Patents

細胞和其它複雜生物材料的色譜分離

Info

Publication number
HK1202335A1
HK1202335A1 HK15102849.2A HK15102849A HK1202335A1 HK 1202335 A1 HK1202335 A1 HK 1202335A1 HK 15102849 A HK15102849 A HK 15102849A HK 1202335 A1 HK1202335 A1 HK 1202335A1
Authority
HK
Hong Kong
Prior art keywords
cells
biological materials
complex biological
chromatographic isolation
chromatographic
Prior art date
Application number
HK15102849.2A
Other languages
English (en)
Inventor
Herbert Stadler
Original Assignee
Juno Therapeutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juno Therapeutics Gmbh filed Critical Juno Therapeutics Gmbh
Publication of HK1202335A1 publication Critical patent/HK1202335A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3823—Affinity chromatography of other types, e.g. avidin, streptavidin, biotin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/405—Concentrating samples by adsorption or absorption
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/7051—T-cell receptor (TcR)-CD3 complex
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70517—CD8

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK15102849.2A 2012-02-23 2015-03-20 細胞和其它複雜生物材料的色譜分離 HK1202335A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261602150P 2012-02-23 2012-02-23
PCT/EP2013/053650 WO2013124474A2 (en) 2012-02-23 2013-02-25 Chromatographic isolation of cells and other complex biological materials

Publications (1)

Publication Number Publication Date
HK1202335A1 true HK1202335A1 (zh) 2015-09-25

Family

ID=47891608

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15102849.2A HK1202335A1 (zh) 2012-02-23 2015-03-20 細胞和其它複雜生物材料的色譜分離

Country Status (11)

Country Link
US (3) US10228312B2 (zh)
EP (1) EP2817625A2 (zh)
JP (4) JP6362543B2 (zh)
CN (2) CN104254780B (zh)
AU (3) AU2013224027B2 (zh)
CA (1) CA2865033C (zh)
HK (1) HK1202335A1 (zh)
IN (1) IN2014DN06475A (zh)
RU (1) RU2746407C1 (zh)
SG (2) SG10201606970UA (zh)
WO (1) WO2013124474A2 (zh)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9637719B2 (en) 2013-12-06 2017-05-02 Douglas T. Gjerde Devices and methods for purification of biological cells
US10228312B2 (en) * 2012-02-23 2019-03-12 Juno Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
DK3083671T3 (da) 2013-12-20 2020-12-07 Hutchinson Fred Cancer Res Mærkede kimære effektormolekyler og receptorer deraf
EP3126027A4 (en) * 2014-04-03 2017-11-01 Douglas T. Gjerde Devices and methods for purification, detection and use of biological cells
IL280738B (en) 2014-04-16 2022-07-01 Juno Therapeutics Gmbh Methods, kits and device for increasing cell populations
EP3647412A1 (en) * 2014-04-23 2020-05-06 Juno Therapeutics, Inc. Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
US11150239B2 (en) 2014-04-30 2021-10-19 Iba Lifesciences Gmbh Method of isolating a target cell
EP2955521A1 (en) * 2014-06-11 2015-12-16 Centre Hospitalier Universitaire Vaudois (CHUV) Methods for separating cells
PT3757206T (pt) * 2014-11-05 2024-05-21 Juno Therapeutics Inc Métodos de transdução e processamento de células
DE202014105965U1 (de) 2014-12-10 2015-01-26 Cell.Copedia GmbH Spritzengehäuse zum Pipettieren eines biologischen Materials mit integrierten Membranen
WO2016166568A1 (en) 2015-04-16 2016-10-20 Juno Therapeutics Gmbh Methods, kits and apparatus for expanding a population of cells
US11827904B2 (en) 2015-04-29 2023-11-28 Fred Hutchinson Cancer Center Modified stem cells and uses thereof
CN105606815A (zh) * 2015-05-18 2016-05-25 烟台载通生物技术有限公司 一种用于免疫检测的多单元装置
MA45488A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés, kits et appareil de culture de cellules
BR112018008111A2 (pt) 2015-10-22 2018-11-06 Juno Therapeutics Gmbh métodos, kits, agentes e aparelhos para transdução
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
GB201521784D0 (en) * 2015-12-10 2016-01-27 Univ Birmingham Cell purification
KR102553195B1 (ko) 2016-07-29 2023-07-07 주노 쎄러퓨티크스 인코퍼레이티드 항-cd19 항체에 대한 항-이디오타입 항체
US10294454B2 (en) 2016-08-24 2019-05-21 General Electric Company Methods and kits for cell activation
CA3043776A1 (en) * 2016-12-23 2018-06-28 Chacko JOSEPH Methods and compositions for purification or isolation of microvesicles and exosomes
US11517627B2 (en) 2017-01-20 2022-12-06 Juno Therapeutics Gmbh Cell surface conjugates and related cell compositions and methods
MA49288A (fr) * 2017-04-27 2020-03-04 Juno Therapeutics Gmbh Reactifs particulaires oligomères et leurs méthodes d'utilisation
WO2019027850A1 (en) 2017-07-29 2019-02-07 Juno Therapeutics, Inc. CELL EXPANSION REAGENTS EXPRESSING RECOMBINANT RECEPTORS
MX2020001490A (es) 2017-08-09 2020-08-06 Juno Therapeutics Inc Metodos para producir composiciones de celulas geneticamente modificadas y composiciones relacionadas.
BR112020011215A2 (pt) 2017-12-08 2020-11-17 Juno Therapeutics Inc processo para a produção de uma composição de células t modificadas
WO2019133842A1 (en) * 2017-12-29 2019-07-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Purification and labeling of extracellular vesicles using a mixed mode resin composition
WO2020018578A1 (en) * 2018-07-17 2020-01-23 University Of Washington Compositions and methods related to aptamer-based reversible cell selection
MX2021001523A (es) 2018-08-09 2021-05-27 Juno Therapeutics Inc Procesos para generar células modificadas y composiciones de las mismas.
MA53612A (fr) 2018-09-11 2021-09-15 Juno Therapeutics Inc Procédés d'analyse par spectrométrie de masse de compositions cellulaires modifiées
KR20210098450A (ko) 2018-10-31 2021-08-10 주노 테라퓨틱스 게엠베하 세포의 선택 및 자극을 위한 방법 및 이를 위한 장치
BR112021008738A2 (pt) 2018-11-06 2021-11-03 Juno Therapeutics Inc Processo para produzir células t geneticamente construídas
EP3980530A1 (en) 2019-06-07 2022-04-13 Juno Therapeutics, Inc. Automated t cell culture
US20220392613A1 (en) 2019-08-30 2022-12-08 Juno Therapeutics, Inc. Machine learning methods for classifying cells
EP4021609A1 (en) * 2019-08-30 2022-07-06 FloDesign Sonics, Inc. Acoustic affinity cell selection for multiple target receptors
AU2020377043A1 (en) 2019-10-30 2022-06-02 Juno Therapeutics Gmbh Cell selection and/or stimulation devices and methods of use
WO2021118873A1 (en) * 2019-12-09 2021-06-17 St. Jude Children's Research Hospital, Inc. Method for preparing cd7-negative, cd3-positive t cells
JP2023512209A (ja) 2020-01-28 2023-03-24 ジュノー セラピューティクス インコーポレイテッド Ｔ細胞形質導入のための方法
CA3163761C (en) 2020-01-31 2023-07-11 Herbert Stadler Methods of isolating a biological entity
MX2022009832A (es) 2020-02-12 2023-02-14 Juno Therapeutics Inc Composiciones de celulas t de receptor de antigeno quimerico dirigido a cd19 y usos de las mismas.
US20230087953A1 (en) 2020-02-12 2023-03-23 Juno Therapeutics, Inc. Bcma-directed chimeric antigen receptor t cell compositions and methods and uses thereof
WO2021231661A2 (en) 2020-05-13 2021-11-18 Juno Therapeutics, Inc. Process for producing donor-batched cells expressing a recombinant receptor
WO2022234009A2 (en) 2021-05-06 2022-11-10 Juno Therapeutics Gmbh Methods for stimulating and transducing t cells
WO2023017115A1 (en) * 2021-08-11 2023-02-16 Iba Lifesciences Gmbh Fractionation of cells based on a marker protein
CN113908589B (zh) * 2021-10-08 2022-09-27 天津工业大学 一种表面印迹抗体的疏水电荷诱导模式膜层析介质及其制备方法
WO2023147510A1 (en) 2022-01-28 2023-08-03 Juno Therapeutics, Inc. Chromatography arrays and related methods and kits
EP4223381A1 (en) * 2022-02-02 2023-08-09 Sartorius BIA Separations d.o.o. Method of purifying or removing a target component from full plasma
WO2023213969A1 (en) 2022-05-05 2023-11-09 Juno Therapeutics Gmbh Viral-binding protein and related reagents, articles, and methods of use
WO2023230581A1 (en) 2022-05-25 2023-11-30 Celgene Corporation Methods of manufacturing t cell therapies
WO2024100604A1 (en) 2022-11-09 2024-05-16 Juno Therapeutics Gmbh Methods for manufacturing engineered immune cells
WO2024124132A1 (en) 2022-12-09 2024-06-13 Juno Therapeutics, Inc. Machine learning methods for predicting cell phenotype using holographic imaging

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583940D1 (de) 1984-10-02 1991-10-02 Harry M Meade Herstellung von streptavidinaehnlichen polypeptiden.
US4851341A (en) 1986-12-19 1989-07-25 Immunex Corporation Immunoaffinity purification system
DE4237113B4 (de) 1992-11-03 2006-10-12 "Iba Gmbh" Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins
WO1996023879A1 (en) 1995-01-30 1996-08-08 Terrapin Technologies, Inc. Glubodies - multiplicities of proteins capable of binding a variety of small molecules
WO1996024606A1 (en) 1995-02-09 1996-08-15 University Of Washington Modified-affinity streptavidin
WO1997011183A1 (en) 1995-04-11 1997-03-27 Trustees Of Boston University Streptavidin mutants
DE19641876B4 (de) 1996-10-10 2011-09-29 Iba Gmbh Streptavidinmuteine
US6368813B1 (en) 1997-03-14 2002-04-09 The Trustees Of Boston University Multiflavor streptavidin
US5985658A (en) 1997-11-14 1999-11-16 Health Research Incorporated Calmodulin-based cell separation technique
DE19932688B4 (de) 1999-07-13 2009-10-08 Scil Proteins Gmbh Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen
EP1227321A1 (en) 2000-12-28 2002-07-31 Institut für Bioanalytik GmbH Reversible MHC multimer staining for functional purification of antigen-specific T cells
DE10113776B4 (de) 2001-03-21 2012-08-09 "Iba Gmbh" Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins
WO2003029462A1 (en) 2001-09-27 2003-04-10 Pieris Proteolab Ag Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
US8076452B2 (en) * 2002-03-01 2011-12-13 Erdmann Volker A Streptavidin-binding peptide
US7754155B2 (en) * 2002-03-15 2010-07-13 Ross Amelia A Devices and methods for isolating target cells
FR2841905B1 (fr) 2002-07-05 2004-09-03 Centre Nat Rech Scient Fragments fab mutants de l'anticorps anti-cd4 chimere 13b8.2 et leurs applications
JP2007512528A (ja) * 2003-11-20 2007-05-17 バイオセンサー、アプリケーションズ、スエーデン、アクチボラグ 所定の抗原混合物に特異的な少なくとも２種類の異なる抗体の混合物およびその混合物の使用
DE602005013957D1 (de) * 2004-06-03 2009-05-28 Meso Scale Technologies Llc Verfahren zur durchführung von vollbluttests
GB0422431D0 (en) * 2004-10-08 2004-11-10 Affitech As Method
EP1800136B1 (en) * 2004-10-15 2011-12-07 Danisco US Inc. Competitive differential screening
US20060252087A1 (en) * 2005-01-18 2006-11-09 Biocept, Inc. Recovery of rare cells using a microchannel apparatus with patterned posts
US7855057B2 (en) 2006-03-23 2010-12-21 Millipore Corporation Protein splice variant/isoform discrimination and quantitative measurements thereof
CN105699662A (zh) * 2006-11-02 2016-06-22 协和梅迪克斯株式会社 免疫测定待测组分的方法
CN101622340A (zh) 2006-11-15 2010-01-06 茵维特罗根戴纳股份公司 生物素化合物与支持物可逆结合的方法
CN101226118B (zh) * 2007-01-19 2010-06-16 中国医学科学院肿瘤研究所 一种兼容免疫荧光分析的细胞化学染色方法及其用途
JP4962215B2 (ja) 2007-08-28 2012-06-27 パナソニック株式会社 墨出し器の精度確認装置及び墨出し器の精度確認方法
SG10201704689XA (en) * 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
JP2011510653A (ja) 2008-01-29 2011-04-07 フレッド ハッチンソン キャンサー リサーチ センター ＣＤ１６１ｈｉおよび／またはＩＬ１８Ｒａｈｉであり、迅速な薬剤流出能力を有するＣＤ８＋Ｔ細胞の同定
EP2363501A1 (en) * 2010-03-02 2011-09-07 Universitätsklinikum Hamburg-Eppendorf Method for isolating target cells
JP6192537B2 (ja) * 2010-08-06 2017-09-06 ルードヴィヒ−マクシミリアン−ウニヴェルズィテート ミュンヘン Ｔ細胞の標的抗原の同定
CN107843730B (zh) 2011-07-18 2021-08-20 Iba生命科学股份有限公司 使靶细胞可逆染色的方法
US10228312B2 (en) 2012-02-23 2019-03-12 Juno Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
IL280738B (en) 2014-04-16 2022-07-01 Juno Therapeutics Gmbh Methods, kits and device for increasing cell populations
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
BR112018008111A2 (pt) 2015-10-22 2018-11-06 Juno Therapeutics Gmbh métodos, kits, agentes e aparelhos para transdução
MA45488A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés, kits et appareil de culture de cellules

Also Published As

Publication number Publication date
US20190234844A1 (en) 2019-08-01
WO2013124474A2 (en) 2013-08-29
JP6362543B2 (ja) 2018-07-25
CA2865033C (en) 2021-11-02
AU2019200178B2 (en) 2021-09-09
JP2015512621A (ja) 2015-04-30
AU2019200178A1 (en) 2019-01-31
CN104254780A (zh) 2014-12-31
CN106940268B (zh) 2021-09-21
AU2021282451A1 (en) 2022-01-06
CN106940268A (zh) 2017-07-11
IN2014DN06475A (zh) 2015-06-12
JP6857626B2 (ja) 2021-04-14
CA2865033A1 (en) 2013-08-29
US20190226951A1 (en) 2019-07-25
AU2013224027A1 (en) 2014-10-02
US20150024411A1 (en) 2015-01-22
AU2013224027B2 (en) 2019-01-24
SG10201606970UA (en) 2016-10-28
WO2013124474A3 (en) 2013-12-05
JP2023016981A (ja) 2023-02-02
JP2018108103A (ja) 2018-07-12
RU2746407C1 (ru) 2021-04-13
JP2021090471A (ja) 2021-06-17
US10228312B2 (en) 2019-03-12
EP2817625A2 (en) 2014-12-31
SG11201404991YA (en) 2014-09-26
JP7192014B2 (ja) 2022-12-19
CN104254780B (zh) 2017-04-12

Similar Documents

Publication Publication Date Title
HK1202335A1 (zh) 細胞和其它複雜生物材料的色譜分離
HK1210494A1 (zh) 用於細胞培養的裝置和方法
HK1205195A1 (zh) 抗體及其使用方法
GB201013989D0 (en) Biological materials and methods of using the same
EP2892562A4 (en) ANTI-MCAM ANTIBODIES AND ASSOCIATED METHOD FOR USE
IL238227A0 (en) Antibodies against c16orf54 and uses thereof
EP2912174A4 (en) METHOD AND MATERIALS FOR ISOLATING NUCLEIC ACID MATERIALS
ZA201404675B (en) Anti-lrp5 antibodies and methods of use
EP2742123A4 (en) ISOLATION AND DETECTION OF CANCER CELLS
HK1211627A1 (zh) 試劑材料和有關的試驗元件
EP2938632A4 (en) ANTI-GRANULYSIN ANTIBODIES AND METHODS OF USE
EP2748337A4 (en) CELL SENSITIVITY ASSAY FOR CANCER AND METHODS OF PRODUCTION AND USE THEREOF
HK1209432A1 (zh) 抗鋸齒蛋白抗體及使用方法
SG11201502497RA (en) Sebocyte cell culturing and methods of use
SG11201503592TA (en) Case for containing biological samples and corresponding method of use
SG11201406771PA (en) Stem cell preparations and methods of use
GB201215352D0 (en) Improvements in and relating to the anaalysis of sample
AU2012900478A0 (en) Preservation of Biological Materials
GB201112000D0 (en) Biological materials and uses thereof
AU2012901799A0 (en) Thermo-Electrochemical Cell and Method of Use